- Home
- AIP vs ABSI Comparison
AIP vs ABSI Comparison
Compare AIP & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIP
- ABSI
- Stock Information
- Founded
- AIP 2003
- ABSI 2011
- Country
- AIP United States
- ABSI United States
- Employees
- AIP N/A
- ABSI N/A
- Industry
- AIP Semiconductors
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- AIP Technology
- ABSI Health Care
- Exchange
- AIP Nasdaq
- ABSI Nasdaq
- Market Cap
- AIP 336.2M
- ABSI 338.0M
- IPO Year
- AIP 2021
- ABSI 2021
- Fundamental
- Price
- AIP $9.02
- ABSI $2.59
- Analyst Decision
- AIP Strong Buy
- ABSI Strong Buy
- Analyst Count
- AIP 3
- ABSI 5
- Target Price
- AIP $15.00
- ABSI $8.40
- AVG Volume (30 Days)
- AIP 626.5K
- ABSI 3.8M
- Earning Date
- AIP 07-31-2025
- ABSI 08-13-2025
- Dividend Yield
- AIP N/A
- ABSI N/A
- EPS Growth
- AIP N/A
- ABSI N/A
- EPS
- AIP N/A
- ABSI N/A
- Revenue
- AIP $61,309,000.00
- ABSI $4,815,000.00
- Revenue This Year
- AIP $19.82
- ABSI $81.76
- Revenue Next Year
- AIP $17.29
- ABSI $287.79
- P/E Ratio
- AIP N/A
- ABSI N/A
- Revenue Growth
- AIP 14.68
- ABSI N/A
- 52 Week Low
- AIP $5.46
- ABSI $2.01
- 52 Week High
- AIP $12.64
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- AIP 57.56
- ABSI 38.62
- Support Level
- AIP $8.10
- ABSI $2.64
- Resistance Level
- AIP $10.11
- ABSI $2.86
- Average True Range (ATR)
- AIP 0.70
- ABSI 0.17
- MACD
- AIP 0.06
- ABSI -0.03
- Stochastic Oscillator
- AIP 50.00
- ABSI 15.87
About AIP Arteris Inc.
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.